Clinical Trials Logo

Clinical Trial Summary

This Study evaluates the performance (sensitivity, specificity, positive and negative predictive value values and likelihood ratios) of the DNA detection test for the diagnosis of mucormycosis by comparing it to the routine tests such as CT scan aspects, histopathology, microscopy and fungal culture, in a test group of 52 patients including : - patients at high-risk according to the EORTC/MSG criteria (patients with prolonged severe neutropenia, receiving corticosteroids or T-cell suppressors, recipients of allogeneic HSCT, or inherited severe immunodeficiency), - patients with other predisposing factors of invasive mould disease ( diabetes, AIDS, haematological malignancies or solid tumours, trauma, burns); Patients already diagnosed with probable or proven mucormycosis irrespective of underlying conditions.


Clinical Trial Description

The patients eligible for this study will already be hospitalized with repeated monitoring of clinical and biological parameters. Participation in the study will result in an additional sampling of blood (estimated volume 6 mL for each sampling) on day of suspicion of the mucormycosis and then twice a week up to a maximum of 8 weeks. vials will be added to the routine sampling of these patients (ie, at the time of routine sampling for galactomannan antigemia), and no new sampling procedure will be required. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02845934
Study type Interventional
Source Centre Hospitalier Universitaire de Besancon
Contact
Status Completed
Phase N/A
Start date January 2014
Completion date January 2018

See also
  Status Clinical Trial Phase
Completed NCT03387696 - Mucormycosis in ICU
Recruiting NCT04744454 - Post Marketing Surveillance (PMS) Study of Cresemba in Korea.
Completed NCT00419770 - The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study Phase 2
Recruiting NCT05925660 - Mucorales PCR Screening in At-risk Hematology Patients N/A
Completed NCT04935463 - Mucormycosis in COVID-19
Completed NCT04550936 - Patterns of Real-World Isavuconazole Use - a Study of Patients With Mucormycosis or Invasive Aspergillosis
Completed NCT05074043 - COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital
Not yet recruiting NCT05406037 - Biomarkers for Invasive Mucormycosis
Completed NCT05348434 - Evaluation of Using 3D Printed PEEK Facial Implants in Repairing Maxillofacial Deformities
Completed NCT05212961 - COVID-19 and Rhino-orbital Mucormycosis
Recruiting NCT05097664 - Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran